Fig. 2From: Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countriesMeasures of clinical burden in APD patients compared with non-APD patients (physician judgement). *p < 0.0001. ADL, activities of daily living; APD, advanced Parkinson’s disease; MMSE, Mini-Mental State Examination; PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease Rating ScaleBack to article page